Gopinathannair R, Chen LY, Chung MK, Cornwell WK, Furie KL, Lakkireddy DR, Marrouche NF, Natale A, Olshansky B, Joglar JA, American Heart Association Electrocardiography and Arrhythmias Committee and Heart Failure and Transplantation Committee of the Council on. Clinical Cardiology; Council on Arteriosclerosis, thrombosis and vascular Biology; Council on Hypertension; Council on lifestyle and cardiometabolic Health; and the stroke Council. Managing atrial fibrillation in patients with heart failure and reduced ejection fraction: a scientific statement from the American heart association. Circ Arrhythm Electrophysiol. 2021;14:HAE0000000000000078. https://doi.org/10.1161/HAE.0000000000000078.

Article  PubMed  Google Scholar 

Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91:2–8. https://doi.org/10.1016/s0002-9149(02)03373-8.

Article  Google Scholar 

Gorter TM, van Veldhuisen DJ, Mulder BA, Artola Arita VA, van Empel VPM, Manintveld OC, Tieleman RG, Maass AH, Vernooy K, van Gelder IC, Rienstra M. Prevalence and incidence of atrial fibrillation in heart failure with mildly reduced or preserved ejection fraction: (Additive) value of implantable loop recorders. J Clin Med. 2023;12:3682. https://doi.org/10.3390/jcm12113682.

Article  PubMed  PubMed Central  Google Scholar 

Chelikam N, Katapadi A, Venkata Pothineni N, Darden D, Kabra R, Gopinathannair R, Lakkireddy D. Epidemiology of atrial fibrillation in heart failure. Card Electrophysiol Clin. 2025;17(1):1–11. https://doi.org/10.1016/j.ccep.2024.08.004.

Article  PubMed  Google Scholar 

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC)Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200. https://doi.org/10.1093/eurheartj/ehw128.

Article  PubMed  Google Scholar 

Aissaoui N, Morshuis M, Maoulida H, Salem JE, Lebreton G, Brunn M, Chatellier G, Hagège A, Schoenbrodt M, Puymirat E, Latremouille C, Varnous S, Ouldamar S, Guillemain R, Diebold B, Guedeney P, Barreira M, Mutuon P, Guerot E, Paluszkiewicz L, Hakim-Meibodi K, Schulz U, Danchin N, Gummert J, Durand-Zaleski I, Leprince P, Fagon JY. Management of end-stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes. Eur J Cardiothorac Surg. 2018;53(1):170–7. https://doi.org/10.1093/ejcts/ezx258.

Article  PubMed  Google Scholar 

Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail. 2017;19:595–602. https://doi.org/10.1002/ejhf.779.

Article  PubMed  Google Scholar 

Gopinathannair R, Cornwell WK, Dukes JW, Ellis CR, Hickey KT, Joglar JA, Pagani FD, Roukoz H, Slaughter MS, Patton KK. Device therapy and arrhythmia management in left ventricular assist device recipients: a scientific statement from the American heart Association. Circulation. 2019;139:e967–89. https://doi.org/10.1161/CIR.0000000000000673

Article  PubMed  Google Scholar 

Deshmukh A, Bhatia A, Anyanwu E, Ota T, Jeevanandam V, Uriel N, Tung R, Ozcan C. Incidence and outcomes of postoperative atrial fibrillation after left ventricular assist device. ASAIO J. 2018;64:581–5. https://doi.org/10.1097/MAT.0000000000000763.

Article  PubMed  PubMed Central  Google Scholar 

Hawkins RB, Mehaffey JH, Guo A, Charles EJ, Speir AM, Rich JB, Quader MA, Ailawadi G, Yarboro LT, Virginia Cardiac Services Quality Initiative. Postoperative atrial fibrillation is associated with increased morbidity and resource utilization after left ventricular assist device placement. J Thorac Cardiovasc Surg. 2018;156:1543–e15494. https://doi.org/10.1016/j.jtcvs.2018.03.169.

Article  PubMed  PubMed Central  Google Scholar 

Enriquez AD, Calenda B, Gandhi PU, Nair AP, Anyanwu AC, Pinney SP. Clinical impact of atrial fibrillation in patients with the heartmate II left ventricular assist device. J Am Coll Cardiol. 2014;64:1883–90. https://doi.org/10.1016/j.jacc.2014.07.989.

Article  PubMed  Google Scholar 

Noll AE, Adewumi J, Amuthan R, Gillombardo CB, Mannan Z, Kiehl EL, Hussein AA, Chung MK, Wazni OM, Starling RC, Soltesz EG, Cantillon DJ. Atrial tachyarrhythmias among patients with left ventricular assist devices: prevalence, clinical outcomes, and impact of rhythm control strategies. JACC Clin Electrophysiol. 2019;5:459–66. https://doi.org/10.1016/j.jacep.2018.11.016.

Article  PubMed  Google Scholar 

Hickey KT, Garan H, Mancini DM, Colombo PC, Naka Y, Sciacca RR, Abrams MP, Solove M, Zeoli N, Flannery M, Garan AR, Biviano AB. Atrial fibrillation in patients with left ventricular assist devices: incidence, predictors, and clinical outcomes. JACC Clin Electrophysiol. 2016;2:793–8. https://doi.org/10.1016/j.jacep.2016.03.009.

Article  PubMed  Google Scholar 

Kadado AJ, Akar JG, Hummel JP. Arrhythmias after left ventricular assist device implantation: incidence and management. Trends Cardiovasc Med. 2018;28:41–50. https://doi.org/10.1016/j.2017.07.002.

Article  PubMed  Google Scholar 

Deshmukh A, Kim G, Burke M, Anyanwu E, Jeevanandam V, Uriel N, Tung R, Ozcan C. Atrial arrhythmias and electroanatomical remodeling in patients with left ventricular assist devices. J Am Heart Assoc. 2017;6:e005340. https://doi.org/10.1161/JAHA.116.005340.

Article  PubMed  PubMed Central  Google Scholar 

Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol. 1994;23:961–9. https://doi.org/10.1016/0735-1097(94)90644-0.

Article  PubMed  CAS  Google Scholar 

Deshmukh A, Bhatia A, Sayer GT, Kim G, Raikhelkar J, Imamura T, Ozcan C, Ota T, Jeevanandam V, Uriel N. Left atrial appendage occlusion with left ventricular assist device decreases thromboembolic events. Ann Thorac Surg. 2019;107(4):1181–6. https://doi.org/10.1016/j.athoracsur.2018.09.004.

Article  PubMed  Google Scholar 

Coisne A, Pilato R, Brigadeau F, Klug D, Marquie C, Souissi Z, Richardson M, Mouton S, Polge AS, Lancellotti P, Lacroix D, Montaigne D. Percutaneous left atrial appendage closure improves left atrial mechanical function through Frank-Starling mechanism. Heart Rhythm. 2017;14:710–6. https://doi.org/10.1016/j.hrthm.2017.01.042.

Article  PubMed  Google Scholar 

.Imamura T, Chung B, Nguyen A, Sayer G, Uriel N. Clinical implications of hemodynamic assessment during left ventricular assist device therapy. J Cardiol. 2018;71:352–8. https://doi.org/10.1016/j.jjcc.2017.12.001.

Article  PubMed  Google Scholar 

Imamura T, Kinugawa K, Ono M, Kinoshita O, Fukushima N, Shiose A, Matsui Y, Yamazaki K, Saiki Y, Usui A, Niinami H, Matsumiya G, Arai H, Sawa Y. Implication of preoperative existence of atrial fibrillation on hemocompatibility-related adverse events during left ventricular assist device support. Circ J. 2019;83:1286–92. https://doi.org/10.1253/circj.CJ-18-1215.

Article  PubMed  Google Scholar 

Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30:1039–45. https://doi.org/10.1016/s0735-1097(97)00254-4.

Article  PubMed  CAS  Google Scholar 

Tantrachoti P, Klomjit S, Vutthikraivit W, Prieto S, Gongora E, Nair N. Impact of preoperative atrial fibrillation in patients with left ventricular assist device: a systematic review and meta-analysis. Artif Organs. 2019;43(12):1135–43. https://doi.org/10.1111/aor.13523.

Article  PubMed  Google Scholar 

Kurihara C, Critsinelis A, Kawabori M, Sugiura T, Civitello AB, Morgan JA. Effect of preoperative atrial fibrillation on patients with chronic heart failure who undergo long-term continuous-flow LVAD implantation. ASAIO J. 2018;64(5):594–600. https://doi.org/10.1097/MAT.0000000000000762.

Article  PubMed  Google Scholar 

Acharya D, Kazui T, Al Rameni D, Acharya T, Betterton E, Juneman E, Loyaga-Rendon R, Lotun K, Shetty R, Chatterjee A. Aortic valve disorders and left ventricular assist devices. Front Cardiovasc Med. 2023;10:1098348. https://doi.org/10.3389/fcvm.2023.1098348.

Article  PubMed  PubMed Central  Google Scholar 

Chung BB, Grinstein JS, Imamura T, Kruse E, Nguyen AB, Narang N, Holzhauser LH, Burkhoff D, Lang RM, Sayer GT, Uriel NY. Biventricular pacing versus right ventricular pacing in patients supported with LVAD. JACC Clin Electrophysiol. 2021;7(8):1003–9. https://doi.org/10.1016/j.jacep.2021.01.016.

Article  PubMed  Google Scholar 

Usman MS, Ahmed S, Yamani N, Akhtar T, Asmi N, Siddiqi TJ, Khan SU, Doukky R, Khan MS. Meta-analysis of the effect of preoperative atrial fibrillation on outcomes after left ventricular assist device implantation. Am J Cardiol. 2019;124:158–62. https://doi.org/10.1016/j.amjcard.2019.03.038.

Article  PubMed  Google Scholar 

Stulak JM, Deo S, Schirger J, Aaronson KD, Park SJ, Joyce LD, Daly RC, Pagani FD. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation. Ann Thorac Surg. 2013;96:2161–7. https://doi.org/10.1016/j.athoracsur.2013.07.004.

Article  PubMed  Google Scholar 

Antonides CFJ, Yalcin YC, Veen KM, Muslem R, De By TMMH, Bogers AJJC, G